Los Angeles Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$497K Sell
5,736
-2,117
-27% -$203K ﹤0.01% 879
2025
Q4
$714K Buy
7,853
+1,737
+28% +$169K ﹤0.01% 761
2025
Q3
$582K Sell
6,116
-8,685
-59% -$798K ﹤0.01% 882
2025
Q2
$1.29M Sell
14,801
-19,504
-57% -$1.65M ﹤0.01% 582
2025
Q1
$3.08M Sell
34,305
-20,645
-38% -$1.85M 0.01% 350
2024
Q4
$4.39M Sell
54,950
-338,796
-86% -$29.3M 0.02% 340
2024
Q3
$35.4M Buy
393,746
+336,730
+591% +$28.3M 0.14% 129
2024
Q2
$4.49M Sell
57,016
-1,977
-3% -$162K 0.02% 343
2024
Q1
$5.14M Buy
58,993
+52,092
+755% +$4.45M 0.02% 347
2023
Q4
$569K Hold
6,901
﹤0.01% 832
2023
Q3
$541K Hold
6,901
﹤0.01% 801
2023
Q2
$608K Sell
6,901
-83
-1% -$7.14K ﹤0.01% 784
2023
Q1
$563K Sell
6,984
-54,824
-89% -$4.47M ﹤0.01% 826
2022
Q4
$4.8M Buy
61,808
+9,491
+18% +$769K 0.02% 382
2022
Q3
$4.22M Sell
52,317
-51,266
-49% -$4.61M 0.02% 386
2022
Q2
$9.3M Sell
103,583
-3,049
-3% -$309K 0.05% 282
2022
Q1
$11.8M Buy
106,632
+14,989
+16% +$1.58M 0.05% 260
2021
Q4
$9.48M Sell
91,643
-149,624
-62% -$17.3M 0.04% 282
2021
Q3
$30.2M Sell
241,267
-947
-0.4% -$123K 0.14% 137
2021
Q2
$30.1M Sell
242,214
-61,012
-20% -$7.66M 0.13% 154
2021
Q1
$35.8M Buy
303,226
+2,659
+0.9% +$312K 0.16% 141
2020
Q4
$35.2M Buy
300,567
+156,669
+109% +$17.2M 0.15% 131
2020
Q3
$15M Sell
143,898
-361,484
-72% -$36.3M 0.07% 200
2020
Q2
$46.3M Buy
505,382
+32,543
+7% +$3.12M 0.22% 104
2020
Q1
$42.6M Buy
472,839
+7,796
+2% +$829K 0.27% 96
2019
Q4
$52.8M Sell
465,043
-5
-0% -$549 0.26% 101
2019
Q3
$50.5M Buy
465,048
+105,535
+29% +$11M 0.27% 93
2019
Q2
$35M Sell
359,513
-193,399
-35% -$17.7M 0.19% 128
2019
Q1
$50.4M Sell
552,912
-54,910
-9% -$4.91M 0.28% 87
2018
Q4
$55.3M Buy
607,822
+332,145
+120% +$31M 0.34% 75
2018
Q3
$27.1M Buy
275,677
+179,040
+185% +$16.6M 0.14% 177
2018
Q2
$8.27M Buy
96,637
+394
+0.4% +$32.9K 0.05% 393
2018
Q1
$7.72M Sell
96,243
-1,300
-1% -$107K 0.04% 366
2017
Q4
$7.88M Sell
97,543
-378,156
-79% -$30.3M 0.04% 372
2017
Q3
$37M Buy
475,699
+45,826
+11% +$3.8M 0.21% 127
2017
Q2
$38.2M Buy
429,873
+348,254
+427% +$29.4M 0.24% 109
2017
Q1
$6.58M Sell
81,619
-14,688
-15% -$1.15M 0.05% 362
2016
Q4
$6.86M Sell
96,307
-78,907
-45% -$6.2M 0.05% 353
2016
Q3
$15.1M Sell
175,214
-22,808
-12% -$1.99M 0.13% 223
2016
Q2
$17.2M Buy
198,022
+149,981
+312% +$12.1M 0.15% 179
2016
Q1
$3.6M Buy
+48,041
New +$3.62M 0.03% 377
2015
Q3
Sell
-3,842
Closed -$285K 1192
2015
Q2
$285K Sell
3,842
-143,323
-97% -$11M ﹤0.01% 1076
2015
Q1
$11.5M Sell
147,165
-30,965
-17% -$2.35M 0.11% 238
2014
Q4
$12.9M Buy
178,130
+47,756
+37% +$3.32M 0.12% 196
2014
Q3
$8.08M Sell
130,374
-32,256
-20% -$2.05M 0.1% 230
2014
Q2
$10.4M Buy
162,630
+32,139
+25% +$1.95M 0.1% 242
2014
Q1
$8.03M Buy
130,491
+1,268
+1% +$73.9K 0.09% 268
2013
Q4
$7.42M Sell
129,223
-226,183
-64% -$12.8M 0.08% 270
2013
Q3
$18.9M Sell
355,406
-51,753
-13% -$2.78M 0.23% 134
2013
Q2
$21M Buy
+407,159
New +$20.1M 0.3% 90

Other funds holding MDT

Los Angeles Capital Management's MDT Position: Q1 2026 in Review

Los Angeles Capital Management reduced its Medtronic (MDT) stake by 27% in Q1 2026, selling an estimated $203K and leaving 5,736 shares worth $497K. The position accounts for ﹤0.01% of the portfolio, ranked #879.

Los Angeles Capital Management first reported a position in MDT in Q2 2013 and has held it in 50 quarters since. The position peaked at $55.3M in Q4 2018. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Los Angeles Capital Management held 5,736 shares of Medtronic worth $497K as of Q1 2026.
  • Los Angeles Capital Management sold 2,117 Medtronic shares in Q1 2026, an estimated $203K.
  • Medtronic made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #879 holding.
  • Los Angeles Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 50 quarters since.
  • Los Angeles Capital Management's Medtronic position peaked at $55.3M in Q4 2018.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.